Brief: Organovo Advances Clinical Timelines For Fxr314 And Provides Updates On Nash Phase 2 Data

VivoSim Labs

23/08/2023 13:15

Aug 23 (Reuters) - 
  
    * ORGANOVO ADVANCES CLINICAL TIMELINES FOR FXR314 AND
PROVIDES
UPDATES ON NASH PHASE 2 DATA
    * ORGANOVO HOLDINGS INC - FULL PHASE 2 DATA IS EXPECTED TO
BE
RELEASED IN 1H 2024
    * ORGANOVO HOLDINGS INC - TO DATE, DRUG HAS BEEN GENERALLY
WELL-TOLERATED, WITH NO TREATMENT-RELATED SERIOUS ADVERSE EVENTS
    * ORGANOVO HOLDINGS INC - CONTINUES TO EXPECT TO FILE INDS
STARTING IN 2025 FOR FULLY INTERNALLY DEVELOPED MOLECULES

Source text for Eikon:  ID:nGNX4dZyr8 
Further company coverage:  ONVO.O 

 ((reuters.briefs@thomsonreuters.com;))